These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3669830)

  • 1. [Nasal concentrations of fusafungin following administration of a dosage aerosol (Locabiosol)].
    Rohdewald P; Lohmann A
    Laryngol Rhinol Otol (Stuttg); 1987 Aug; 66(8):416-9. PubMed ID: 3669830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Albert A; Delporte JP; Gustin P
    J Vet Pharmacol Ther; 2010 Apr; 33(2):183-8. PubMed ID: 20444043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative determination of protein, albumin, and antibiotics in nasal secretions of healthy probands (author's transl)].
    Giebel W; Schönleber KH; Breuninger H; Ullmann U
    Arch Otorhinolaryngol; 1979; 225(2):149-59. PubMed ID: 533454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Granulometry and measurement of a aerosol drug deposit (fusafungine) in normal and pathological airways].
    Bouchikhi A; Becquemin MH; Bertholon JF; Roy M; Harpey C; Stahlhofen W; Nizar Z
    Rev Pneumol Clin; 1994; 50(6):309-15. PubMed ID: 7701210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fusafungin: tolerance and mode of action].
    Natale F
    Arch Monaldi; 1980; 35(4):185-92. PubMed ID: 7044334
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of doxycycline in pigs following oral administration in feed.
    Bousquet E; Nouws J; Terlouw P; de Kleyne S
    Vet Res; 1998; 29(5):475-85. PubMed ID: 9779560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bioavailability of mupirocin in nasal secretions in vitro.
    Hill RL
    J Clin Pathol; 2002 Mar; 55(3):233-5. PubMed ID: 11896081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of telithromycin into the nasal mucosa and ethmoid bone of patients undergoing rhinosurgery for chronic sinusitis.
    Kuehnel TS; Schurr C; Lotter K; Kees F
    J Antimicrob Chemother; 2005 Apr; 55(4):591-4. PubMed ID: 15761076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alteration of nasal resistance before and after local exposure to heated aerosol in perennial allergic rhinitis.
    Naito K; Miyata S; Baba R; Mamiya T; Senoh Y; Iwata S; Yokoyama N; Yamakawa S; Ibata K
    Rhinology; 1999 Jun; 37(2):66-8. PubMed ID: 10416251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of isolated acute laryngitis with fusafungin. A phase IV study].
    Hamann KF
    HNO; 1994 Feb; 42(2):113-8. PubMed ID: 8163395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.
    Moller W; Saba GK; Haussinger K; Becker S; Keller M; Schuschnig U
    Rhinology; 2011 Aug; 49(3):286-91. PubMed ID: 21858257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acoustic rhinometry in the assessment of the topical treatment of upper respiratory infections with fusafungin].
    Samoliński B; Grzanka A; Zawisza E; Arcimowicz M
    Otolaryngol Pol; 1998; 52(3):327-34. PubMed ID: 9760777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety assessment program of fusafungin in the treatment of acute upper respiratory tract infections in adults (PROFIL): multicenter study in Poland].
    Jurkiewicz D; Ochwat A
    Pol Merkur Lekarski; 2003 Mar; 14(81):189-93. PubMed ID: 12914091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of histological methods for the demonstration of the anti-inflammatory activity of fusafungin (author's transl)].
    Jousserandot P; Gremain J; du Boistesselin R
    Sem Hop; 1981 Jan 18-25; 57(3-4):143-50. PubMed ID: 6261353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment of rhinosinusitis with fusafungine nasal spray. A double-blind, placebo-controlled, parallel-group study in 20 patients.
    Mösges R; Spaeth J; Berger K; Dubois F
    Arzneimittelforschung; 2002; 52(12):877-83. PubMed ID: 12572527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal administration of drugs.
    Scheibe M; Bethge C; Witt M; Hummel T
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):643-6. PubMed ID: 18559733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topical drops and sprays on mucociliary transport time and nasal air flow.
    Bercin S; Ural A; Kutluhan A
    Acta Otolaryngol; 2009 Nov; 129(11):1257-61. PubMed ID: 19863321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled azithromycin therapy.
    Hickey AJ; Lu D; Ashley ED; Stout J
    J Aerosol Med; 2006; 19(1):54-60. PubMed ID: 16551215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.